How can developing countries maximize some of the beneficial rules and policies provided to them by the EU and international organizations to reduce public health plight in terms of inadequate access to medicines and vaccines? By navigating some of the complex European and international rules and policies that have hitherto been put in place to ease access to affordable healthcare, the author identifies ways in which policy makers and legislators can optimally use extant rules to enhance healthcare provision.In addition, the Act allowed for the use of parallel trade to attenuate the impact of high prices of medicines that are needed by the population. ... The EC like the USA did not clearly come out in favour of the Government of South Africa. ... to affordable medicines in the South EC position on the controversy surrounding actions of pharmaceutical companies South Africa in 1997 and its position in Thailand.
|Title||:||Access to Medicines and Vaccines in the South|
|Publisher||:||ASP / VUBPRESS / UPA - 2012-01-01|